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Abstract
Background: In mice, the cytokine interleukin (IL)-17A causes a local accumulation of neutrophils
within the bronchoalveolar space. IL-17A may thereby also contribute to an increased local
proteolytic burden. In the current study, we determined whether mRNA for IL-17A is elevated and
protein expression of IL-17A occurs locally in inflammatory cells within the human bronchoalveolar
space during severe inflammation caused by organic dust. We also assessed the expression of the
elastinolytic protease MMP-9 in this airway compartment.
Methods: Six healthy, non-smoking human volunteers were exposed to organic dust in a swine
confinement, a potent stimulus of neutrophil accumulation within the human bronchoalveolar
space. Bronchoalveolar lavage (BAL) fluid was harvested 2 weeks before and 24 hours after the
exposure and total and differential counts were conducted for inflammatory BAL cells. Messenger
RNA for IL-17A was measured using reverse transcript polymerase chain reaction-enzyme linked
immunoassay (RT-PCR-ELISA). Intracellular immunoreactivity (IR) for IL-17A and MMP-9,
respectively, was determined in BAL cells.
Results: The exposure to organic dust caused more than a forty-fold increase of mRNA for IL-
17A in BAL cells. IL-17A immunoreactivity was detected mainly in BAL lymphocytes, and the
number of these IL-17A expressing lymphocytes displayed an eight-fold increase, even though not
statistically significant. The increase in IL-17A mRNA was associated with a substantial increase of
the number of BAL neutrophils expressing MMP-9 immunoreactivity.
Conclusion:  Exposure to organic dust increases local IL-17A mRNA and because there is
intracellular expression in BAL lymphocytes, this suggests that IL-17A protein can originate from
lymphocytes within the human bronchoalveolar space. The fact that the increased IL-17A mRNA
is associated with an increased number of MMP-9-expressing neutrophils is compatible with IL-17A
increasing the local proteolytic burden through its neutrophil-accumulating effect.
Published: 25 May 2005
Respiratory Research 2005, 6:44 doi:10.1186/1465-9921-6-44
Received: 08 November 2004
Accepted: 25 May 2005
This article is available from: http://respiratory-research.com/content/6/1/44
© 2005 Ivanov et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Respiratory Research 2005, 6:44 http://respiratory-research.com/content/6/1/44
Page 2 of 8
(page number not for citation purposes)
Introduction
Several chronic lung diseases are associated with an exag-
gerated accumulation and activity of neutrophils locally
in the human bronchoalveolar space [1]. These lung dis-
eases include acute, severe asthma, chronic bronchitis and
chronic obstructive pulmonary disease (COPD) [1]. Neu-
trophils may play a pathogenic role in these diseases
through the release of free oxygen radicals and by produc-
ing enzymes that increase the local proteolytic burden.
Thus, via these compounds, neutrophils may contribute
to pathogenic hallmarks such as non-specific bronchial
hyper-responsiveness and hypersecretion, as well as to
epithelial damage and tissue remodelling [1].
There is evidence that, among the proteolytic enzymes in
the lungs, matrix metalloproteinase (MMP)-9 plays an
important pathogenic role and this is most likely due to
its capacity to cleave structural proteins such as collagens
and elastin [2]. In support of this, local MMP-9 is
increased in asthma and in COPD [3-8]. It is believed that
neutrophils constitute an important source of MMP-9 in
the lungs, even though macrophages, bronchial epithelial
cells and fibroblasts may also produce MMP-9 under cer-
tain conditions [2].
Recent studies on mice in vivo and on human cells in vitro
are compatible with activated T-lymphocytes contributing
to the local accumulation of neutrophils in the broncho-
alveolar space through the release of the cytokine inter-
leukin (IL)-17A. However it remains unknown whether
lymphocytes producing IL-17A actually reside within the
bronchoalveolar space of humans [1]. In the bronchoalve-
olar space of mice and rats, local administration of recom-
binant IL-17A protein increases the number of
neutrophils substantially [1,9]. Systemic pre-treatment
with a neutralizing anti-IL-17A antibody attenuates endo-
toxin-induced neutrophil accumulation in the same com-
partment of mice [10]. It is likely that IL-17A causes this
neutrophil accumulation in part indirectly through the
induced production of neutrophil-mobilizing cytokines,
such as granulocyte-macrophage colony-stimulating fac-
tor (GMC-SF), IL-6 and IL-8, in local cells, including bron-
chial epithelial cells, fibroblasts and smooth muscle cells
[1,10]. In addition, there are now studies on mice and rats
indicating that IL-17A may control the local proteolytic
burden in the bronchoalveolar space in vivo through its
impact on neutrophil accumulation [11,12].
We recently showed that organic dust in a swine confine-
ment, a strong stimulus of neutrophilic inflammation,
causes a substantial increase in the concentration of free,
soluble IL-17A protein in the human bronchoalveolar
space [13]. Interestingly, this increase in local IL-17A pro-
tein is associated not only with an accumulation of neu-
trophils but also with an accumulation of lymphocytes.
The current study was undertaken to determine whether
these lymphocytes can produce IL-17A in humans. The
study was also undertaken to address whether production
of IL-17A is associated with an increased local proteolytic
burden from neutrophils. Exposure to organic dust in a
swine confinement was utilised as a pro-inflammatory
stimulus and intracellular expression of MMP-9 was tar-
geted as a sign of proteolytic burden in the bronchoalveo-
lar space of human healthy volunteers.
Methods
Study design
The study protocol was approved by the Ethics Committee
at Karolinska Institute (Diary N. KI 95:347). Six healthy,
non-smoking volunteers gave their written consent to par-
ticipate in the study after receiving both written and oral
information.
All the participants were non-atopic, non-asthmatic as
determined by history and questionnaire. They were
exposed to organic dust while weighing pigs in a swine
confinement (ie. a barn) during three hours, as previously
described [14-16]. The procedure incorporates exposure
to aerosolised organic dust, with a concentration of
approximately 24 mg dust and 1.2 µg endotoxin per m3,
as assessed in a recent study [13]. Normal lung function
and normal airway responsiveness were ascertained in all
subjects prior to exposure. The subjects underwent bron-
choscopy with bronchoalveolar lavage (BAL-see below) 2
weeks before and 24 hours after the exposure.
Lung function
Spirometry was performed in accordance with the criteria
of the American Thoracic Society using a low-resistance
rolling-seal spirometer (OHIO model 840; Airco, Madi-
son, WI, USA) [17]. Swedish reference values were used
[18,19].
Bronchial responsiveness
The methacholine provocation test was conducted prior
to exposure to ascertain a normal airway function, as pre-
viously described [20]. Briefly, after the inhalation of the
diluent (vehicle) alone, doubling concentrations of meth-
acholine were given starting at 0,5 and ending at 32 mg/
ml. The test was stopped either at a FEV1 decrease of 20%,
compared to the value registered after the inhalation of
the diluent, or after inhalation of the highest metha-
choline provocation (32 mg/ml). The cumulative dose
causing a 20% decrease of FEV1  (PD20FEV1) was
calculated.
Bronchoalveolar lavage
Bronchoscopy and bronchoalveolar lavage were per-
formed according to standard procedures previously
described [13]. In short, after pre-medication withRespiratory Research 2005, 6:44 http://respiratory-research.com/content/6/1/44
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morphine-scopolamine, a flexible fibreoptic broncho-
scope (Olympus Type 4B2; Olympus Optical Co. Ltd.,
Shinjukuku, Tokyo, Japan) was inserted through the nose
under local anaesthesia with lidocaine (Xylocain R, Astra,
Södertälje, Sweden). The bronchoscope was wedged in a
middle lobe bronchus and a total of 250 ml of sterile
saline at 37°C was instilled in 5 aliquots of 50 ml. After
each instillation, the BAL suspension was gently aspirated
and collected in a siliconized plastic bottle kept on ice.
After sterile filtration (70 µm filter), the BAL suspension
was centrifuged (Hereus Omnifuge 300 g, 10 min, +4°C).
The cell-free supernatant was kept frozen (-80°C) until
analysis. The cell pellet was resuspended (phosphate-buff-
ered saline [PBS]: 5 ml). Viability of cells was assessed
using trypan blue exclusion and the total cell number (ie.
concentration) was determined for each sample in a
Bürker chamber. BAL cytospin samples were prepared and
stained (May-Grünwald-Giemsa) and differential cell
counts were performed using light microscopy (Zeiss Axi-
opaln 2, Carl Zeiss, Jena, Germany).
Messenger RNA for IL-17A
Remaining cells from the resuspended pellet were centri-
fuged (see above) and the supernatant was removed. The
cell pellet was re-suspended (PBS: 50 µl plus RNAlater
from Ambion Inc, Austin, USA: 250 µl per 3 × 106 cells),
transferred into microtubes, (3 × 106 cells per tube) and
incubated (24 hrs, +4°C). The RNeasy minikit was used
according to the manufacturer's protocol with the follow-
ing modification: The eluted RNA was treated with Dnase
I (Rnase-Free Dnase set: 30 min, 37°C). After this, the
steps from adjusting binding conditions to eluting RNA
were repeated.
The eluted total RNA was measured for quantity and
purity using spectrophotometry (SpectraMaxPlus®Molec-
ular Devices Corporation Sunnyvale, CA, USA; absorb-
ance at 260 and 260/280 nm respectively) and then stored
frozen (-83°C) until purification of Total RNA.
The RT-PCR ELISA technique was employed to quantify
relative changes in the IL-17A mRNA gene transcript. A
one-step RT-PCR was utilized with a Gene Amp PCR sys-
tem 2400 (Perkin Elmer, Wellesley, MA, USA) for ampli-
fication. Each RT-PCR of 50 µl was conducted using 100
ng of total cellular RNA and 30 pmol of each primer, 10 U
RNase inhibitor (recombinant RNasin, Promega Corpora-
tion, Madison, WI, USA), 200 µM PCR DIG Labelling mix
(20 µM dATP, dGTP, dCTP each plus 19 µM dTTP plus 1
µM DIG-dUTP), 5 mM DDT, 10 µl RT-PCR reaction buffer
(1.5 mM Mg+), 1 µl Titan enzyme mix (AMV reverse tran-
scriptase+Taq DNA polymerase+Pwo DNA polymerase)
or 0,5 µl Expand high fidelity PCR system (Taq DNA
polymerase+Pwo DNA polymerase) for DNA controls (all
reagents from Roche Diagnostics). Reverse transcription
was performed (30 min, 50°C). The IL-17A and the
house-keeping gene HPRT were subsequently annealed
(55°C). IL-17A and HPRT were then amplified (35 and 30
cycles, respectively) and the DIG labelled PCR product
was stored frozen (-20°C) before the detection step. RT-
PCRs were performed in duplicate. Gene sequences were
accessed from NCBI Database and accession number used
was for human (h) HPRT V00530 and for hIL-17 U32659.
Scandinavian Gene Synthesis AB (Köping, Sweden) pro-
vided the oligonucleotides.
The gene primer sequences used for RT-PCR and ELISA
detection:
hHPRT
Sense (5') 5'CGT CGT GAT TAG TGA TGA TGA AC3'
Antisense (3') 5'GCA AAG TCT GCA TTG TTT TGC CA3'
Internal probe 5'GAG GCC ATC ACA TTG TAG CCC TCT
GTG3'
hIL-17
Sense (5') 5' GTG AAG GCA GGA ATC ACA ATC 3'
Antisense (5') 5' ACC AGG ATC TCT TGC TGG AT 3'
Internal probe 5' CAG AGT TCA TGT GGT AGT CCA CGT
TCC CA 3'
The DIG labelled PCR products were denaturated and
hybridized with the biotinylated internal probe specifi-
cally designed to hybridize with each gene PCR product,
and immobilized on streptavidin coated microtiter plates
(3 hrs, 42°C), utilising the PCR ELISA DIG-detection kit
(Roche). After washing, the bound PCR-products were
incubated (30 min, 37°C) with an anti-DIG-horseradish
peroxidase conjugated antibody followed by reaction (20
min) with the substrate 2,2'-azino-di(3-ethyl benzthiazo-
line sulfonate) (ABTS). The absorbance was then meas-
ured using spectrophotometry (see above, at 405/492
nm) in an ELISA plate reader (Labsystems Multiscan Mul-
tisoft, Vanda, Finland). The expression of transcripts for
IL-17 mRNA was normalized to the expression of HPRT
transcripts and shown as percent of the house-keeping
gene (% HPRT). In parallel with tested samples, control
samples for PCR, probe specificity, DNA contamination,
hybridisation and sample dilution were run.Respiratory Research 2005, 6:44 http://respiratory-research.com/content/6/1/44
Page 4 of 8
(page number not for citation purposes)
Immunocytochemistry (ICC)
General procedure
BAL cells were fixed with formaldehyde (2%, 30 min, on
ice) and washed twice in buffer prior to making cytospin
preparations. Air-dried samples were stored frozen (-
80°C) until further use. After thawing, samples were
treated with donkey serum (10%) to avoid unspecific
binding. Endogenous biotin was blocked using the Biotin
Blocking System (DAKO corporation, Glostrup,
Denmark).
IL-17A immunoreactivity (IR)
The intracellular expression of IL-17A protein was
assessed utilising cytospin slides incubated with a polyclo-
nal goat anti-human IL-17A antibody (R&D: 1 hr). As sec-
ondary antibody, a biotinylated F(ab')2 fragment donkey
anti-goat IgG (Jackson ImmunoResearch laboratories Inc)
was used, followed by alkaline phosphatase-conjugated
streptavidin (DAKO). All the solutions above were sup-
plemented with saponin (Sigma: 0.1 %), to permeabilise
cell membrane. Bound antibodies were visualised with
Vector Red Alkaline Substrate Kit (Vector Laboratories,
Inc. Burlingame, CA, USA). Mayer's Hematoxylin (Sigma)
was used for counterstaining.
MMP-9 immunoreactivity
The intracellular expression of MMP-9 protein was
assessed utilising cytospin slides incubated with a polyclo-
nal goat anti-human MMP-9 (R&D: 1 hr). The secondary
antibody and the detection system were the same as for IL-
17A (see above).
Human neutrophilic lipocalin
The concentration of the neutrophil-specific activity
marker human neutrophilic lipocalin (HNL) was meas-
ured in cell-free BAL fluid using a solid phase, double-lig-
and radioimmunoassay as described elsewhere [21].
Data analyses
Data are presented as median (range) values unless other-
wise stated. The analysis of differences between measure-
ments prior to and after the exposure, were conducted
utilizing the sign test, assuming binominal distribution.
To avoid falsely positive conclusions, the significance
level at each test was set to 0.05/3 (ie. 0.0167), since three
key variables (IL-17A mRNA, IL-17 IR and MMP9 IR) were
compared in the current material. n refers to number of
human subjects.
Results
Clinical characteristics prior to exposure
Four males and 2 females with a median age of 22 (19–
24) were included in the study. There were no apparent
gender-related differences in pulmonary function of the
subjects. FEV1 was 96 (92 – 105) % of predicted value and
vital capacity 98 (90–102) % predicted value. All subjects
had normal bronchial responsiveness to metacholine
(PD20FEV1 for metacholine: 5.3 [1.7–15] mg).
Cells in BAL fluid
The BAL recovery volume was similar before (195 [170–
234] ml) and after (196 [190–212] ml) the exposure. The
exposure caused more than a two-fold increase in the total
BAL cell number, more than a five-fold increase in the
number of lymphocytes and more than a ten-fold increase
in the number of neutrophils.(Table 1).
Messenger RNA for IL-17A
Before the exposure, 4 out of 6 persons displayed no
detectable levels of mRNA for IL-17A, whereas all six sub-
jects displayed detectable and increased levels after the
exposure (fig. 1).
IL-17A immunoreactivity
IL-17A immunoreactivity was mainly detected in BAL
lymphocytes (fig. 2). In addition, the percentage of lym-
phocytes positive for IL-17A immunoreactivity (fig. 3)
tended to increase in 5 out of 6 subjects after the exposure.
In contrast, a much lower fraction of macrophages
expressed a weak signal for IL-17A immunoreactivity and
there was no pronounced increase in this signal after the
exposure (data not shown). BAL neutrophils did not dis-
play IL-17A immunoreactivity (data not shown)
MMP-9 immunoreactivity
Neutrophils were the prevailing cell type in BAL fluid
expressing MMP-9 immunoreactivity (fig. 4) and this sig-
nal was substantially increased after exposure (fig. 5).
However, the fraction of neutrophils (% all neutrophils)
expressing MMP-9 immunoreactivity was not increased
after exposure (data not shown). Very few macrophages
expressed MMP-9 immunoreactivity and this signal was
consistently weak (data not shown).
HNL
The exposure did not cause any substantial increase in the
concentration of free, soluble HNL in the BAL fluid, even
though there was a weak average trend in this direction
Table 1: Concentration of BAL cells. BAL cells before and after 
exposure to organic dust in a swine confinement. Data are 
presented as 1 × 106/L median (range).
Cell type Before After
Total cells 71,3 (57,9–80,9) 165,1 (98,2–365,6)
Lymphocytes 4,4 (1,2–10.0) 23,1 (9,8–61,6)
Neutrophils 2,3 (0,8–3,6) 23,1 (6,6–167,3)Respiratory Research 2005, 6:44 http://respiratory-research.com/content/6/1/44
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(data not shown). Furthermore, the amount of HNL per
neutrophil tended to be decreased after exposure (data
not shown).
Discussion
The current study demonstrates that, in previously healthy
human volunteers, exposure to organic dust substantially
increases the messenger RNA for IL-17A in BAL cells. Our
study also demonstrates that lymphocytes constitute the
predominant cell type that expresses intracellular IL-17A
protein among BAL cells. The demonstrated increase in IL-
17A mRNA is associated with an increased absolute
number of MMP-9 expressing BAL neutrophils at the same
time point.
The aerosolised organic dust in a swine confinement, that
was utilised as a pro-inflammatory stimulus in our study,
is a more complex stimulus than endotoxin, because of its
mixed content of grain dust, ammonia, fungi, Gram-posi-
tive and Gram-negative bacteria [15]. It has previously
been shown that exposure to this type of organic dust
causes severe inflammation in the bronchoalveolar space
of humans [13,15,16]. Our current study now adds to
these previous studies novel evidence of de novo synthesis
of IL-17A by local cells within the bronchoalveolar space
of humans [1]. Furthermore, our study forwards lym-
phocytes as a local source of IL-17A protein in the human
bronchoalveolar space, because the intracellular immu-
noreactivity for this specific protein was found mainly in
certain BAL lymphocytes. Noteworthy, even though this
immunoreactivity should be regarded as a qualitative
assessment primarily, it was increased eight-fold by aver-
age after exposure with only one subject lacking a detect-
able increase. Clearly, this is compatible with
lymphocytes accounting for production of IL-17A protein
in the bronchoalveolar space of humans. Indeed, our cur-
rent results are supported by our previous demonstration
of an increase in the final consequence of the increased
transcription and intracellular loading of protein, namely
in free, soluble IL-17A protein in cell-free BAL fluid [13].
It is also noteworthy that in our current study, certain but
not all lymphocytes in the human bronchoalveolar space
express IL-17A protein after exposure to organic dust. This
observation is compatible with previous studies on acti-
vated mouse CD4+ and CD8+ lymphocytes from BAL and
spleen as well as human CD4+ and CD8+ lymphocytes
Messenger RNA for IL-17A in BAL cells Figure 1
Messenger RNA for IL-17A in BAL cells. Messenger 
RNA for IL-17A in BAL cells (percentage of the house-keep-
ing gene HPRT), measured 2 weeks before and 24 hours 
after exposure to organic dust in a swine confinement. Data 
are shown as individual (rhombs) plus median (bold horizon-
tal lines) values. *: p < 0,0167; n = 6
Immunocytochemical detection of IL-17A protein in BAL  lymphocytes Figure 2
Immunocytochemical detection of IL-17A protein in 
BAL lymphocytes. BAL lymphocytes expressing IL-17A IR 
(brown arrows) after exposure to organic dust in a swine 
confinement, detected using immunocytochemistry.Respiratory Research 2005, 6:44 http://respiratory-research.com/content/6/1/44
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from blood [1,22-28]. Taken together, these observations
warrant new specific cellular targets for additional analy-
sis in future studies on human airways.
We assessed intracellular immunoreactivity for MMP-9 as
a marker of proteolytic burden, both before and after
exposure to organic dust. Even though some of the BAL
macrophages displayed a very weak expression of MMP-9
immunoreactivity, as has previously been reported in a
different inflammatory setting [29], we found the most
pronounced increase in and expression of MMP-9 immu-
noreactivity consistently among BAL neutrophils. This
observation fully supports that neutrophils can constitute
an important source of MMP-9 in the human bronchoal-
veolar space in vivo, at least after exposure to organic dust.
At the same time point after the exposure, the MMP-9
expression in neutrophils was associated with an increase
in mRNA for IL-17A, even though the fraction (percent-
age) of neutrophils expressing MMP-9 was not increased.
This is compatible with IL-17A indirectly contributing to
the local proteolytic load, mainly through its increasing
effect on the number of neutrophils within the human
bronchoalveolar space; a type of mechanism supported by
previous studies on the bronchoalveolar space of mice in
vivo [9,12].
BAL lymphocytes expressing IL-17A protein Figure 3
BAL lymphocytes expressing IL-17A protein. Percent-
age of BAL lymphocytes expressing IL-17A IR before and 
after the exposure to organic dust in a swine confinement. 
Data are shown as individual (rhombs) plus median (bold 
horizontal lines) values. NS: p > 0,0167; n = 6
Immunocytochemical detection of MMP-9 protein in BAL  neutrophils Figure 4
Immunocytochemical detection of MMP-9 protein in 
BAL neutrophils. Abundance of BAL neutrophils positive 
for MMP-9 IR (purple arrows) after exposure to organic dust 
in a swine confinement.
BAL neutrophils expressing MMP-9 protein Figure 5
BAL neutrophils expressing MMP-9 protein. BAL neu-
trophils expressing MMP-9 IR (percent of total cells) before 
and after exposure to organic dust in a swine confinement. 
Data are shown as individual (rhombs) plus median (bold 
horizontal lines) values. *: p < 0,0167; n = 5.Respiratory Research 2005, 6:44 http://respiratory-research.com/content/6/1/44
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We also measured the concentration of free, soluble HNL
protein in BAL fluid, as an assessment of neutrophil-spe-
cific activity [30]. However, we detected only a weak aver-
age trend towards a modest increase in the HNL
concentration after exposure to organic dust and this
increase did not even correspond to the substantial
increase in neutrophil number; the amount of HNL per
neutrophil was actually decreased after the exposure. Fur-
thermore some subjects displayed even a decrease in the
total HNL concentration after exposure. Moreover, sepa-
rate and preliminary assessments of the myeloperoxidase
(MPO) concentration in BAL fluid displayed a weak
increase not corresponding to the increase in neutrophil
number (data not shown). Similar findings on MPO and
neutrophils have previously been published [31]. Taken
together, all these findings imply that, in terms of MPO
and HNL, there is actually no true increase in the average
activity of each accumulated neutrophil in the human
bronchoalveolar space after exposure to organic dust.
Again, from a mechanistical point of view, this finding in
the bronchoalveolar space of humans is supported by our
recently published findings on the effect of recombinant
IL-17A in the bronchoalveolar space of mice in vivo [12].
This IL-17A induces an increase of MMP-9 protein and in
corresponding gelatinase activity, that is due to an
increased number of neutrophils rather than an increased
amount of MMP-9 per neutrophil [12].
In conclusion, supported by our recent study showing a
corresponding increase in free, soluble IL-17A protein
[13], the current study adds novel evidence for organic
dust inducing de novo synthesis of IL-17A protein in a sub-
set of local lymphocytes within the human bronchoalve-
olar space. Our current study on humans also adds
evidence compatible with induced de novo synthesis of IL-
17A being associated with an increased proteolytic burden
due to a local accumulation of neutrophils rather than an
increased activity in each of these inflammatory cells.
Interventional studies will be required to determine
whether targeting IL-17A is therapeutically beneficial in
lung diseases characterised by excessive accumulation of
neutrophils.
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